Literature DB >> 25785792

Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries.

Sharon R Sznitman1, Tanya Kolobov2, Tom ter Bogt3, Emmanuel Kuntsche4, Sophie D Walsh5, Yossi Harel-Fisch6.   

Abstract

OBJECTIVE: This research examined whether national population-level cannabis frequency rates moderate the strength of the relationship between individual-level psychosocial and behavioral risk factors (poor parental communication, bullying, fighting, etc.) and different levels of adolescent cannabis use (abstinence, experimental use, and regular use).
METHOD: Data from the 2009/2010 Health Behaviour in School-Aged Children survey (N = 62,009, age = 15 years) from 31 countries were analyzed using multinomial hierarchical linear modeling.
RESULTS: Analyses showed that adolescents who reported experimental cannabis use and who lived in relatively high cannabis frequency countries were less likely than their counterparts in low cannabis frequency countries to present some of the cannabis-related psychosocial and behavioral risk factors. Conversely, regular cannabis use tended to occur among high-risk adolescents to an equal degree in high and low cannabis frequency countries.
CONCLUSIONS: The findings suggest that the normality of cannabis use in the youth population is important to consider when investigating the relationship between risk factors and cannabis use.

Entities:  

Mesh:

Year:  2015        PMID: 25785792     DOI: 10.15288/jsad.2015.76.181

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  8 in total

1.  "Is Marijuana Even a Drug?" A Qualitative Study of How Teens View Marijuana Use and Why They Use It.

Authors:  Bettina Friese
Journal:  J Psychoactive Drugs       Date:  2017-02-26

2.  Cannabis cessation among youth: rates, patterns and academic outcomes in a large prospective cohort of Canadian high school students.

Authors:  Alexandra M Zuckermann; Mahmood R Gohari; Margaret de Groh; Ying Jiang; Scott T Leatherdale
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-04       Impact factor: 3.240

Review 3.  Evidence for Sex Convergence in Prevalence of Cannabis Use: A Systematic Review and Meta-Regression.

Authors:  Cath Chapman; Tim Slade; Wendy Swift; Katherine Keyes; Zoe Tonks; Maree Teesson
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

4.  Adolescents' Intense and Problematic Social Media Use and Their Well-Being in 29 Countries.

Authors:  Maartje Boer; Regina J J M van den Eijnden; Meyran Boniel-Nissim; Suzy-Lai Wong; Joanna C Inchley; Petr Badura; Wendy M Craig; Inese Gobina; Dorota Kleszczewska; Helena J Klanšček; Gonneke W J M Stevens
Journal:  J Adolesc Health       Date:  2020-06       Impact factor: 5.012

5.  Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use.

Authors:  Grace Blest-Hopley; Aisling O'Neill; Robin Wilson; Vincent Giampietro; Sagnik Bhattacharyya
Journal:  Psychopharmacology (Berl)       Date:  2019-12-09       Impact factor: 4.530

6.  Risk Behaviors, Family Support, and Emotional Health among Adolescents during the COVID-19 Pandemic in Israel.

Authors:  Orit Shapiro; Rachel Nissanholtz Gannot; Gizell Green; Avi Zigdon; Moti Zwilling; Ariela Giladi; Lilach Ben-Meir; Marques Adilson; Sharon Barak; Yossi Harel-Fisch; Riki Tesler
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

7.  Individual and school-class correlates of youth cannabis use in Sweden: A multilevel study.

Authors:  Patrik Karlsson; Mats Ekendahl; Isabella Gripe; Jonas Raninen
Journal:  Nordisk Alkohol Nark       Date:  2018-03-19

8.  Has illicit drug use become normalised in groups of Swedish youth? A latent class analysis of school survey data from 2012 to 2015.

Authors:  Patrik Karlsson; Mats Ekendahl; Josefin Månsson; Jonas Raninen
Journal:  Nordisk Alkohol Nark       Date:  2018-12-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.